Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 7,284 $ 4,787
Marketable debt securities 8,969
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 691 1,737
Total current assets 8,025 15,543
Non-current assets:    
Leasehold improvements and equipment - net 468 1,923
Operating lease right-of-use assets - net 1,680 3,064
Finance lease right-of-use assets - net 8 21
In-process research and development 2,260 3,017
Goodwill 1,336
Restricted cash - security deposit 200 200
Total non-current assets 4,616 9,561
Total assets 12,641 25,104
Current liabilities:    
Accounts payable 95 514
Accrued expenses and other liabilities 1,805 1,447
Operating lease liabilities - current 761 656
Financing lease liabilities - current 5 5
Total current liabilities 2,666 2,622
Non-current liabilities:    
Deferred tax liability 257 341
Operating lease liabilities - net of current portion 2,116 2,877
Financing lease liabilities - net of current portion 12 18
Total non-current liabilities 2,385 3,236
Total liabilities 5,051 5,858
Stockholders’ equity:    
Common stock par value $0.0001 per share, 250,000,000 shares authorized at December 31, 2024 and 2023, respectively; 5,086,985 and 4,345,291 issued and outstanding as of December 31, 2024 and 2023, respectively 1
Additional paid-in capital 207,413 195,040
Accumulated deficit (199,824) (175,573)
Accumulated other comprehensive loss (221)
Total stockholders’ equity 7,590 19,246
Total liabilities and stockholders’ equity $ 12,641 $ 25,104